Thymus derivative active after oral administration, methods of p

Details Thymus derivative active after oral administration, methods of p Thymus derivative active after oral administration, methods of p

1987-06-11

1990-02-27

Phillips, Delbert R.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

530301, 530344, 530395, 530399, 530412, 530837, 530854, A61K 3702, C07K 114, C07K 302, C07K 1500

Patent

active

049046438

ABSTRACT:
Thymolymphotropin, a thymus derivative able to stimulate the differentiation and the function of T-lymphycytes, is active after oral administration and can be prepared through a process of partial acid lysis of mammal thymuses. Pharmaceutical compositions containing thymolymphotropin are utilized in the treatment of primary and secondary immunodeficiencies.

REFERENCES:
patent: 4077949 (1978-03-01), Goldstein
patent: 4250084 (1981-02-01), Trainin
patent: 4374828 (1983-02-01), Folkers et al.
patent: 4377511 (1983-03-01), Lopukhim et al.
patent: 4388234 (1983-06-01), Horecker
patent: 4500450 (1985-02-01), Seipke
patent: 4571336 (1986-02-01), Houck et al.
Lehminger, Biochemistry, 2nd edition, Worth publishers, Inc. (pp. 100-101, 225-226) 1975.

Affiliated with

Also associated with

Rating

Thymus derivative active after oral administration, methods of p does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Thymus derivative active after oral administration, methods of p, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thymus derivative active after oral administration, methods of p will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-174244